Skip to main content

Fel-O-Vax Lv-K IV + CaliciVax

This page contains information on Fel-O-Vax Lv-K IV + CaliciVax for veterinary use.
The information provided typically includes the following:
  • Fel-O-Vax Lv-K IV + CaliciVax Indications
  • Warnings and cautions for Fel-O-Vax Lv-K IV + CaliciVax
  • Direction and dosage information for Fel-O-Vax Lv-K IV + CaliciVax

Fel-O-Vax Lv-K IV + CaliciVax

This treatment applies to the following species:
Company: Elanco US

Feline Leukemia-Rhinotracheitis-Calici-Panleukopenia-Chlamydia Psittaci Vaccine

Killed Virus, Killed Chlamydia

For use in animals only

This product has been shown to be effective for vaccination of healthy cats 8 weeks of age or older against feline leukemia, rhinotracheitis, calici, and panleukopenia viruses and feline chlamydia psittaci. The duration of immunity for this product has not been established. For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov.

The vaccine contains one additional feline calicivirus strain isolated from one hemorrhagic calicivirus outbreak that occurred in 1998 and was shown to be effective for the vaccination of cats against calicivirus-induced hemorrhagic disease in controlled vaccination challenge experiments.

Dose: Inject one 1 mL dose subcutaneously using aseptic technique. Healthy cats should receive two doses, 3 to 4 weeks apart, except that if the animal is less than 16 weeks of age, the final dose should be given no earlier than 16 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity in cats and additional boosters will be required in most young animals. The need for annual booster vaccinations has not been established for this product. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.

Fel-O-Vax Lv-K IV + CaliciVax Caution

Store in the dark at 2° to 8°C (35° to 46°F). AVOID FREEZING. SHAKE WELL. Do not mix with other products, except as specified on the label. This product has not been tested in pregnant animals. In case of anaphylactoid reaction, administer epinephrine. In case of human exposure, contact a physician.

Thimerosal, neomycin, polymyxin B and amphotericin B added as preservatives.

Fel-O-Vax Lv-K IV + CaliciVax Caution

In the absence of a veterinarian-client-patient relationship, Federal law prohibits the relabeling, repackaging, resale, or redistribution of the individual contents of this package.

Fel-O-Vax Lv-K, CaliciVax, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates.

© 2017 Elanco US Inc. all rights reserved.

Elanco US Inc., Fort Dodge, Iowa 50501

Phone: 888-545-5973

VLN/PCN 196/1559.23

25 Doses

25-1 mL Vials of Vaccine

YL102110X

CPN: 1943023.2

ELANCO US INC.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Customer Service:   317-276-1262
Technical Service:   800-428-4441
Website:   www.elanco.us
Email:   elanco@elanco.com
THIS SERVICE AND DATA ARE PROVIDED "AS IS". DVMetrics assumes no liability, and each user assumes full risk, responsibility, and liability, related to its use of the DVMetrics service and data. See the Terms of Use for further details.

Copyright © 2024 Animalytix LLC. Updated: 2024-02-27